Clinical Trial Update: Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and initial clinical activity of AMP-110 in subjects with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AMP-110

Snippet

Sponsor: MedImmune LLC | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED